In conclusion, this first prospective study of the Dutch JDM population supports the use of IFN-induced biomarkers Galectin-9 and CXCL10 and whole-body MRI in JDM diagnostics. The gene discussed is IFNA1; the disease is juvenile dermatomyositis.